Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Aug 2;23(8):1225-1227.
doi: 10.1093/neuonc/noab112.

Converging evidence for inhibition of transcriptional control in high-grade gliomas

Nathan A Dahl  1   2 , Rajeev Vibhakar  1   2
Affiliations
Editorial

Converging evidence for inhibition of transcriptional control in high-grade gliomas

Nathan A Dahl et al. Neuro Oncol. .
No abstract available

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Transcriptional control as a therapeutic vulnerability in high-grade gliomas. Schematic of RNA polymerase II initiation and elongation control by transcriptional CDKs. Citations reflect studies identifying steps as therapeutic targets in high-grade gliomas. Citations in blue indicate studies in pediatric H3K27M-mutant diffuse intrinsic pontine glioma. Abbreviation: CDKs, cyclin-dependent kinases.
See this image and copyright information in PMC

Comment on

References

    1. Miller TE, Liau BB, Wallace LC, et al. . Transcription elongation factors represent in vivo cancer dependencies in glioblastoma. Nature. 2017;547(7663):355–359. - PMC - PubMed
    1. Greenall SA, Lim YC, Mitchell CB, et al. . Cyclin-dependent kinase 7 is a therapeutic target in high-grade glioma. Oncogenesis. 2017;6(5):e336. - PMC - PubMed
    1. Meng W, Wang J, Wang B, et al. . CDK7 inhibition is a novel therapeutic strategy against GBM both in vitro and in vivo. Cancer Manag Res. 2018;10:5747–5758. - PMC - PubMed
    1. Fukasawa K, Kadota T, Horie T, et al. . CDK8 maintains stemness and tumorigenicity of glioma stem cells by regulating the c-MYC pathway. Oncogene. 2021;40(15):2803–2815. - PubMed
    1. Xie Q, Wu Q, Kim L, et al. . RBPJ maintains brain tumor-initiating cells through CDK9-mediated transcriptional elongation. J Clin Invest. 2016;126(7):2757–2772. - PMC - PubMed